Safety and efficacy of the RTS,S/AS01_E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trialKWAKU POKU ASANTE; ABDULLA, Salim; SALIM, Nahya et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 10, pp 741-749, issn 1473-3099, 9 p.Article

Evaluation of the Safety and Immunogenicity of the RTS,S/AS01_E Malaria Candidate Vaccine When Integrated in the Expanded Program of ImmunizationAGNANDJI, Selidji T; ASANTE, Kwaku Poku; CHIKAWE, Maria et al.The Journal of infectious diseases. 2010, Vol 202, Num 7, pp 1076-1087, issn 0022-1899, 12 p.Article

Capillary refill time as an independent prognostic indicator in severe and complicated malariaEVANS, Jennifer A; MAY, Juergen; SYLVERKEN, Justice et al.The Journal of pediatrics. 2006, Vol 149, Num 5, pp 676-681, issn 0022-3476, 6 p.Article

Genome-wide association study indicates two novel resistance loci for severe malariaTIMMANN, Christian; THYE, Thorsten; ANSONG, Daniel et al.Nature (London). 2012, Vol 489, Num 7416, pp 443-446, issn 0028-0836, 4 p.Article